Talapo Therapeutics, Inc.

Biotechnology company · La Jolla, California, United States

Talapo Therapeutics, Inc. is a biotechnology company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2016. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $515,114 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $99,999 sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Talapo Therapeutics at a glance

Typebiotechnology company
HeadquartersLa Jolla, California, United States
Earliest incorporation on record2016
Employees (self-reported, 2018)1
SEC CIK1725002

What does Talapo Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $515,114 in total (2018). NIH funding came from the National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $99,999 sold (2017).

Frequently asked questions about Talapo Therapeutics

Where is Talapo Therapeutics headquartered?

Talapo Therapeutics, Inc. is headquartered in La Jolla, California, United States.

What does Talapo Therapeutics do?

Talapo Therapeutics, Inc. is a biotechnology company.

When was Talapo Therapeutics founded?

The earliest incorporation on record for Talapo Therapeutics, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences